triheptanoin has been researched along with Alzheimer Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Du, H; Guo, L; Pascual, JM; Sun, H; Tandon, N; Tian, J; Wang, L; Yuan, X | 1 |
Aso, E; Calpena, A; Escolano, C; Ferrer, I; Halbaut, L; Joda, L; Perales, JC; Semak, V; Semakova, J | 1 |
2 other study(ies) available for triheptanoin and Alzheimer Disease
Article | Year |
---|---|
Triheptanoin Mitigates Brain ATP Depletion and Mitochondrial Dysfunction in a Mouse Model of Alzheimer's Disease.
Topics: Adenosine Triphosphate; Alzheimer Disease; Animals; Citric Acid Cycle; Disease Models, Animal; Energy Metabolism; Fatty Acids; Hippocampus; Mice; Mice, Transgenic; Mitochondria; Oxidation-Reduction; Triglycerides | 2020 |
Triheptanoin supplementation to ketogenic diet curbs cognitive impairment in APP/PS1 mice used as a model of familial Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Diet, Ketogenic; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunohistochemistry; Maze Learning; Mice; Mice, Transgenic; Real-Time Polymerase Chain Reaction; Triglycerides | 2013 |